A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

ClinicalTrials.gov ID: NCT05897320

Public ClinicalTrials.gov record NCT05897320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 18, 2026, 4:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Eptinezumab in Paediatric Patients (6 to 17 Years) for the Preventive Treatment of Episodic Migraine

Study identification

NCT ID: NCT05897320
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: H. Lundbeck A/S; Industry
Enrollment: 315 participants

Conditions and interventions

Conditions

Episodic Migraine

Interventions

Eptinezumab Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 6 Years to 17 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 7, 2023
Primary completion: Jul 5, 2027
Completion: Aug 30, 2027
Last update posted: Mar 11, 2026

2023 – 2027

United States locations

U.S. sites: 15
U.S. states: 12
U.S. cities: 15

Facility	City	State	ZIP	Site status
Ki Health Partners LLC DBA New England Institute for Clinical Research	Stamford	Connecticut	06905-1206	Recruiting
Child Neurology of NW Florida	Gulf Breeze	Florida	32561-4495	Recruiting
AGA Clinical Trials	Hialeah	Florida	33012	Recruiting
University of South Florida - 13330 USF Laurel Dr	Tampa	Florida	33620	Recruiting
Clinical Integrative Research Center of Atlanta	Atlanta	Georgia	30328-6191	Recruiting
University of Kentucky HealthCare (UKHC) Kentucky Clinic	Lexington	Kentucky	40508-1683	Recruiting
University of Maryland School of Medicine	Baltimore	Maryland	21201-1544	Recruiting
Michigan Head Pain and Neurological Institute	Ann Arbor	Michigan	48104-5131	Completed
North Suffolk Neurology-Commack	Commack	New York	11725-2808	Recruiting
OnSite Clinical Solutions, LLC - Randolph Rd - Charlotte	Charlotte	North Carolina	28211-5027	Completed
Childrens Hospital Medical Center of Akron	Akron	Ohio	44308-1063	Recruiting
Cincinnati Children's Hospital Medical Center - PIN	Cincinnati	Ohio	45229-3026	Recruiting
Road Runner Research Ltd	San Antonio	Texas	78249-3539	Recruiting
Children's Specialty Group - 3 Commercial Place	Norfolk	Virginia	23510	Recruiting
Childrens Hospital of Wisconsin - PIN	New Berlin	Wisconsin	53151-7494	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05897320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 11, 2026 · Synced May 18, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05897320 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →